Multimodal imaging for radiation therapy planning in patients with primary prostate cancer-Reference-Cited by-同舟云学术

Multimodal imaging for radiation therapy planning in patients with primary prostate cancer

Published:2018-10 Issue: Volume:8 Page:8-16
ISSN:2405-6316
Container-title:Physics and Imaging in Radiation Oncology
language:en
Short-container-title:Physics and Imaging in Radiation Oncology

Author:

Zamboglou Constantinos,Eiber Matthias,Fassbender Thomas R.,Eder Matthias,Kirste Simon,Bock Michael,Schilling Oliver,Reichel Kathrin,van der Heide Uulke A.,Grosu Anca L.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Radiation

Reference112 articles.

1. EAU-ESTRO-SIOG Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;European Urology,2017

2. Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy;Martinez;Int J Radiat Oncol Biol Phys,2011

3. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes;Zelefsky;Int J Radiat Oncol Biol Phys,2008

4. Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with gleason score 9–10 prostate cancer;Kishan;JAMA,2018

5. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy;Current Oncology;2023-09-27

2. Developing quality assurance tests for simultaneous Positron Emission Tomography – Magnetic Resonance imaging for radiotherapy planning;Physics and Imaging in Radiation Oncology;2022-04

3. A statistical, voxelised model of prostate cancer for biologically optimised radiotherapy;Physics and Imaging in Radiation Oncology;2022-01

4. Optimisation and validation of an integrated magnetic resonance imaging-only radiotherapy planning solution;Physics and Imaging in Radiation Oncology;2021-10

5. [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer;Pharmaceuticals;2021-07-23